| ppvipd {jarbes} | R Documentation |
Efficacy of Pneumococcal Polysaccharide Vaccine in Preventing Invasive Pneumococcal Disease
Description
PPV23 (23-valent pneumococcal polysaccharide vaccine) with 3 Randomized Clinical Trials; 5 Cohort Studies and 3 Case-Control Studies.
The outcome variable IPD (Invasive Pneumococcal Disease).
Format
A matrix with 11 rows and 6 columns. Each row represents study results, the columns are:
- name
Name of the first author and year.
- TE
Treatment Effect as Log Odds Ratio.
- seTE
Standard Error of the TE.
- n.v
Number of patients in the vaccination group.
- n.c
Number of patients in the control group.
- design
Description of the study design.
Source
The data were obtainded from: Falkenhorst et al. (2017).
References
Falkenhorst, G., Remschmidt, C., Harder, T., Hummers-Pradier, E., Wichmann, O., and Bogdan, C. (2017) Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine(PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis. PLoS ONE 12(1): e0169368. doi:10.1371/journal.pone.0169368.
Verde, P.E. and Curcio, D. (2017) Hierarchical Meta-Regression Modelling: The Case of The Pneumococcal Polysaccharide Vaccine. Technical Report.